Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Toshihiro Miyamoto
2019

Prophylactic antiemetics for haematological malignancies: Prospective nationwide survey subset analysis in Japan

Yoshida, I., Tamura, K., Miyamoto, T., Shimokawa, M., Takamatsu, Y., Nanya, Y., Matsumura, I., Gotoh, M., Igarashi, T., Takahashi, T., Aiba, K., Kumagai, K., Ishizawa, K., Kurita, N., Usui, N. & Hatake, K., Jan 1 2019, In : In Vivo. 33, 4, p. 1355-1362 8 p.

Research output: Contribution to journalArticle

Open Access
2011

Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review

Kamimura, T., Miyamoto, T., Nagafuji, K., Numata, A., Henzan, H., Takase, K., Ito, Y., Ohno, Y., Fujisaki, T., Eto, T., Takamatsu, Y., Teshima, T., Gondo, H., Akashi, K., Taniguchi, S. & Harada, M., Jun 1 2011, In : Bone Marrow Transplantation. 46, 6, p. 820-826 7 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)
2013

Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment

Yamauchi, T., Takenaka, K., Urata, S., Shima, T., Kikushige, Y., Tokuyama, T., Iwamoto, C., Nishihara, M., Iwasaki, H., Miyamoto, T., Honma, N., Nakao, M., Matozaki, T. & Akashi, K., Feb 21 2013, In : Blood. 121, 8, p. 1316-1325 10 p.

Research output: Contribution to journalArticle

61 Citations (Scopus)
2015

Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

Takashima, S., Miyamoto, T., Kamimura, T., Yoshimoto, G., Yoshida, S., Henzan, H., Takase, K., Kato, K., Ito, Y., Ohno, Y., Nagafuji, K., Eto, T., Teshima, T. & Akashi, K., Dec 1 2015, In : International journal of hematology. 102, 6, p. 689-696 8 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2013
27 Citations (Scopus)
2018

Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation, Apr 2018, In : Biology of Blood and Marrow Transplantation. 24, 4, p. 832-839 8 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission

For the Japan Study Group for Cell Therapy and Transplantation (JSCT), Apr 1 2018, In : International journal of hematology. 107, 4, p. 468-477 10 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2013

Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma

Muta, T., Miyamoto, T., Fujisaki, T., Ohno, Y., Kamimura, T., Kato, K., Takenaka, K., Iwasaki, H., Eto, T., Takamatsu, Y., Teshima, T. & Akashi, K., Jan 10 2013, In : Internal Medicine. 52, 1, p. 63-70 8 p.

Research output: Contribution to journalArticle

33 Citations (Scopus)
2020

Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma

Fukuoka Blood and Marrow Transplantation Group, May 1 2020, In : International journal of hematology. 111, 5, p. 673-680 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2014

Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning

Koyama, M., Hashimoto, D., Nagafuji, K., Eto, T., Ohno, Y., Aoyama, K., Iwasaki, H., Miyamoto, T., Hill, G. R., Akashi, K. & Teshima, T., Jan 1 2014, In : Bone Marrow Transplantation. 49, 1, p. 110-115 6 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2013

High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib

Kamimura, T., Miyamoto, T., Yokota, N., Aoki, T., Ito, Y. & Akashi, K., Dec 1 2013, In : International journal of hematology. 98, 6, p. 694-701 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2018

Successful treatment of Ph ALL with hematopoietic stem cell transplantation from the same HLA-haploidentical related donor of previous liver transplantation

Sasaki, K., Mori, Y., Yoshimoto, G., Sakoda, T., Kato, K., Inadomi, K., Kamezaki, K., Takenaka, K., Iwasaki, H., Maeda, T., Miyamoto, T. & Akashi, K., Aug 3 2018, In : Leukemia and Lymphoma. 59, 8, p. 2005-2007 3 p.

Research output: Contribution to journalEditorial

1 Citation (Scopus)
2011

Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting

Mori, Y., Miyawaki, K., Kato, K., Takenaka, K., Iwasaki, H., Harada, N., Miyamoto, T., Akashi, K. & Teshima, T., Oct 11 2011, In : Internal Medicine. 50, 19, p. 2149-2155 7 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)
2016

Ascites retention during mogamulizumab treatment in a patient with adult T-cell leukemia/lymphoma

Shima, T., Kamezaki, K., Higashioka, K., Takashima, S., Yoshimoto, G., Kato, K., Muta, T., Takenaka, K., Iwasaki, H., Miyamoto, T. & Akashi, K., Jan 1 2016, In : Internal Medicine. 55, 13, p. 1793-1796 4 p.

Research output: Contribution to journalArticle

2017

Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation

Ogata, M., Oshima, K., Ikebe, T., Takano, K., Kanamori, H., Kondo, T., Ueda, Y., Mori, T., Hashimoto, H., Ogawa, H., Eto, T., Ueki, T., Miyamoto, T., Ichinohe, T. & Atsuta, Y., Nov 1 2017, In : Bone Marrow Transplantation. 52, 11, p. 1563-1570 8 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)
2012

Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma

Kamimura, T., Miyamoto, T., Takashima, S., Yokota, N., Chong, Y., Ito, Y. & Akashi, K., Oct 1 2012, In : International journal of hematology. 96, 4, p. 525-527 3 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)
2013

Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: A multicenter phase 2 study

Takamatsu, Y., Sunami, K., Muta, T., Morimoto, H., Miyamoto, T., Higuchi, M., Uozumi, K., Hata, H. & Tamura, K., Aug 1 2013, In : International journal of hematology. 98, 2, p. 179-185 7 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
2019

Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Mar 1 2019, In : Bone Marrow Transplantation. 54, 3, p. 432-441 10 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)
2018

Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study

Usuki, K., Sakura, T., Kobayashi, Y., Miyamoto, T., Iida, H., Morita, S., Bahceci, E., Kaneko, M., Kusano, M., Yamada, S., Takeshita, S., Miyawaki, S. & Naoe, T., Oct 2018, In : Cancer Science. 109, 10, p. 3235-3244 10 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)
2016

Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04)

Murayama, T., Fukuda, T., Okumura, H., Sunami, K., Sawazaki, A., Maeda, Y., Tsurumi, H., Uike, N., Hidaka, T., Takatsuka, Y., Eto, T., Tsuda, H., Fujisaki, T., Miyamoto, T., Tsuneyoshi, N., Iyama, S., Nagafuji, K. & Harada, M., Jun 1 2016, In : International journal of hematology. 103, 6, p. 676-685 10 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2011
1 Citation (Scopus)
2015

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning

on behalf of the Japan Study Group for Cell Therapy and Transplantation, Sep 1 2015, In : Biology of Blood and Marrow Transplantation. 21, 9, p. 1646-1652 7 p.

Research output: Contribution to journalArticle

40 Citations (Scopus)

A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch

on behalf of the HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jul 1 2015, In : American Journal of Hematology. 90, 7, p. 618-623 6 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2011

Analysis of immune reconstitution after autologous CD34 + stem/progenitor cell transplantation for systemic sclerosis: Predominant reconstitution of Th1 CD4 + t cells

Tsukamoto, H., Nagafuji, K., Horiuchi, T., Mitoma, H., Niiro, H., Arinobu, Y., Inoue, Y., To, K., Miyamoto, T., Iwasaki, H., Teshima, T., Harada, M. & Akashi, K., May 1 2011, In : Rheumatology. 50, 5, p. 944-952 9 p., keq414.

Research output: Contribution to journalArticle

37 Citations (Scopus)
2015

CD41 marks the initial myelo-erythroid lineage specification in adult mouse hematopoiesis: Redefinition of murine common myeloid progenitor

Miyawaki, K., Arinobu, Y., Iwasaki, H., Kohno, K., Tsuzuki, H., Iino, T., Shima, T., Kikushige, Y., Takenaka, K., Miyamoto, T. & Akashi, K., Mar 1 2015, In : STEM CELLS. 33, 3, p. 976-987 12 p.

Research output: Contribution to journalArticle

28 Citations (Scopus)
2013

Detection of minimal residual disease in patients with multiple myeloma using clonotype-specific PCR primers designed from DNA extracted from archival bone marrow slides

Takamatsu, H., Ogawa, Y., Kobayashi, N., Obata, K., Narisawa, T., Nakayama, K., Munemoto, S., Aoki, G., Ohata, K., Kumano, Y., Ozaki, J., Murata, R., Kondo, Y., Terasaki, Y., Kurokawa, T., Miyamoto, T., Shimizu, N., Fukushima, T., Yoshida, A., Ueda, T. & 2 others, Yoshida, T. & Nakao, S., Oct 1 2013, In : Experimental Hematology. 41, 10, p. 894-902 9 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2014

Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis

Kikushige, Y. & Miyamoto, T., Oct 9 2014, In : International journal of hematology. 100, 4, p. 335-340 6 p.

Research output: Contribution to journalReview article

14 Citations (Scopus)
2019
2013
50 Citations (Scopus)

Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: Results of a prospective study (ALL MRD2002 Study)

Nagafuji, K., Miyamoto, T., Eto, T., Kamimura, T., Taniguchi, S., Okamura, T., Ohtsuka, E., Yoshida, T., Higuchi, M., Yoshimoto, G., Fujisaki, T., Abe, Y., Takamatsu, Y., Yokota, S., Akashi, K. & Harada, M., Feb 8 2013, In : Journal of Hematology and Oncology. 6, 1, 14.

Research output: Contribution to journalArticle

21 Citations (Scopus)
2011

Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia

Kikushige, Y., Ishikawa, F., Miyamoto, T., Shima, T., Urata, S., Yoshimoto, G., Mori, Y., Iino, T., Yamauchi, T., Eto, T., Niiro, H., Iwasaki, H., Takenaka, K. & Akashi, K., Aug 16 2011, In : Cancer Cell. 20, 2, p. 246-259 14 p.

Research output: Contribution to journalArticle

173 Citations (Scopus)
2012

Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era

Mori, Y., Miyamoto, T., Kamezaki, K., Kato, K., Kikushige, Y., Takashima, S., Urata, S., Shimoda, S., Shimono, N., Takenaka, K., Iwasaki, H., Nagafuji, K., Teshima, T. & Akashi, K., Aug 1 2012, In : American Journal of Hematology. 87, 8, p. 828-830 3 p.

Research output: Contribution to journalLetter

6 Citations (Scopus)
2017

Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia

Mizutani, M., Takami, A., Hara, M., Mizuno, S., Yanada, M., Chou, T., Uchiyama, H., Ohashi, K., Miyamoto, T., Ozawa, Y., Imataki, O., Kobayashi, N., Uchida, N., Kanamori, H., Kamimura, T., Eto, T., Onizuka, M., Tanaka, J., Atsuta, Y. & Yano, S., Sep 2017, In : Biology of Blood and Marrow Transplantation. 23, 9, p. 1447-1454 8 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia

Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation, Dec 2017, In : Biology of Blood and Marrow Transplantation. 23, 12, p. 2137-2142 6 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2016

Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease

Sugio, T., Kato, K., Aoki, T., Ohta, T., Saito, N., Yoshida, S., Kawano, I., Henzan, H., Kadowaki, M., Takase, K., Muta, T., Miyawaki, K., Yamauchi, T., Shima, T., Takashima, S., Mori, Y., Yoshimoto, G., Kamezaki, K., Takenaka, K., Iwasaki, H. & 6 others, Ogawa, R., Ohno, Y., Eto, T., Kamimura, T., Miyamoto, T. & Akashi, K., Sep 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 9, p. 1608-1614 7 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)
2015

Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era

Takamatsu, H., Honda, S., Miyamoto, T., Yokoyama, K., Hagiwara, S., Ito, T., Tomita, N., Iida, S., Iwasaki, T., Sakamaki, H., Suzuki, R. & Sunami, K., Feb 1 2015, In : Cancer Science. 106, 2, p. 179-185 7 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)
2017

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program

Medical Committee of Japan Marrow Donor Program, Japanese Data Center for Hematopoietic Cell Transplantation, Jun 2017, In : Biology of Blood and Marrow Transplantation. 23, 6, p. 938-944 7 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)
2015

Successful treatment of adult Langerhans cell histiocytosis with intensified chemotherapy

Minami, M., Shima, T., Kato, K., Yamamoto, H., Tsuchihashi, K., Oku, S., Shimokawa, T., Tochigi, T., Yoshimoto, G., Kamezaki, K., Takenaka, K., Iwasaki, H., Oda, Y., Miyamoto, T. & Akashi, K., Aug 11 2015, In : International journal of hematology. 102, 2, p. 244-248 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2017

Identification of unipotent megakaryocyte progenitors in human hematopoiesis

Miyawaki, K., Iwasaki, H., Jiromaru, T., Kusumoto, H., Yurino, A., Sugio, T., Uehara, Y., Odawara, J., Daitoku, S., Kunisaki, Y., Mori, Y., Arinobu, Y., Tsuzuki, H., Kikushige, Y., Iino, T., Kato, K., Takenaka, K., Miyamoto, T., Maeda, T. & Akashi, K., Jun 22 2017, In : Blood. 129, 25, p. 3332-3343 12 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)
2011

[Specific surface markers of AML-leukemic stem cells].

Kikushige, Y., Miyamoto, T. & Akashi, K., Jul 1 2011, In : [Rinshō ketsueki] The Japanese journal of clinical hematology. 52, 7, p. 531-534 4 p.

Research output: Contribution to journalReview article

2020
Open Access
2018

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan

Kawajiri-Manako, C., Sakaida, E., Ohwada, C., Miyamoto, T., Azuma, T., Taguchi, J., Mori, T., Hasegawa, Y., Kondo, T., Yujiri, T., Yoshimitsu, M., Imada, K., Kurahashi, S., Kahata, K., Ichinohe, T., Hirokawa, M., Atsuta, Y. & Nakaseko, C., Jun 2018, In : Biology of Blood and Marrow Transplantation. 24, 6, p. 1180-1186 7 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2019

Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team

Uchida, M., Nakamura, T., Watanabe, H., Kato, K., Miyamoto, T., Akashi, K. & Masuda, S., 2019, In : Pharmazie. 74, 9, p. 566-569 4 p.

Research output: Contribution to journalArticle

2017

Comparison between antiemetic effects of palonosetron and granisetron on chemotherapy-induced nausea and vomiting in Japanese patients treated with R-CHOP

Uchida, M., Mori, Y., Nakamura, T., Kato, K., Kamezaki, K., Takenaka, K., Shiratsuchi, M., Kadoyama, K., Miyamoto, T. & Akashi, K., 2017, In : Biological and Pharmaceutical Bulletin. 40, 9, p. 1499-1505 7 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2013

Effectiveness and safety of antiemetic aprepitant in japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation

Uchida, M., Ikesue, H., Miyamoto, T., Kato, K., Suetsugu, K., Ichinose, K., Hiraiwa, H., Sakurai, A., Takenaka, K., Muta, T., Iwasaki, H., Teshima, T., Shiratsuchi, M., Egashira, N., Akashi, K. & Oishi, R., May 1 2013, In : Biological and Pharmaceutical Bulletin. 36, 5, p. 819-824 6 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)
2019

Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy

Uchida, M., Nakamura, T., Shima, T., Mori, Y., Yoshimoto, G., Kato, K., Shimokawa, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2019, In : Pharmazie. 74, 4, p. 250-254 5 p.

Research output: Contribution to journalArticle

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Nagafuji, K., Matsumura, I., Shimose, T., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., Kadowaki, N., Ishikawa, J., Imamura, Y., Yamazaki, H., Akashi, K. & Kanakura, Y., Dec 1 2019, In : International journal of hematology. 110, 6, p. 675-682 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2020

Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome

Mori, T., Shiratori, S., Suzumiya, J., Kurokawa, M., Shindo, M., Naoyuki, U., Katsuto, T., Miyamoto, T., Morishige, S., Hirokawa, M., Fukuda, T., Atsuta, Y. & Suzuki, R., 2020, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

2014

Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Ogura, M., Ishida, T., Inagaki, H., Yamamoto, K., Ueda, R., Hatake, K., Tobinai, K., Akinaga, S., Taniwaki, M., Ando, K., Fujimoto, K., Miyamoto, T., Uike, N., Tamura, K., Tanimoto, M., Tsukasaki, K., Tomonaga, M., Ishizawa, K. & Suzumiya, J., Apr 10 2014, In : Journal of Clinical Oncology. 32, 11, p. 1157-1163 7 p.

Research output: Contribution to journalArticle

203 Citations (Scopus)
2015

Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: A randomized phase II study

Ishida, T., Jo, T., Takemoto, S., Suzushima, H., Uozumi, K., Yamamoto, K., Uike, N., Saburi, Y., Nosaka, K., Utsunomiya, A., Tobinai, K., Fujiwara, H., Ishitsuka, K., Yoshida, S., Taira, N., Moriuchi, Y., Imada, K., Miyamoto, T., Akinaga, S., Tomonaga, M. & 1 others, Ueda, R., Jun 1 2015, In : British Journal of Haematology. 169, 5, p. 672-682 11 p.

Research output: Contribution to journalArticle

106 Citations (Scopus)